WallStreetZenWallStreetZen

NYSE: ABT
Abbott Laboratories Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ABT

Based on 13 analysts offering 12 month price targets for Abbott Laboratories

Min Forecast
$117.00+0.89%
Avg Forecast
$130.62+12.63%
Max Forecast
$149.00+28.48%

Should I buy or sell ABT stock?

Based on 13 analysts offering ratings for Abbott Laboratories.

Buy
Strong Buy
4 analysts 30.77%
Buy
5 analysts 38.46%
Hold
4 analysts 30.77%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their ABT stock forecasts and price targets.

ABT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-11-05
lockedlocked$00.00+00.00%2024-10-17
lockedlocked$00.00+00.00%2024-10-17
lockedlocked$00.00+00.00%2024-10-17
lockedlocked$00.00+00.00%2024-10-17
Piper Sandler
Top 16%
85
Strong BuyMaintains$133.00+14.68%2024-10-17
Morgan Stanley
Top 11%
90
HoldMaintains$117.00+0.89%2024-10-17
Raymond James
Top 16%
85
BuyMaintains$129.00+11.24%2024-10-14
RBC Capital
Top 25%
76
BuyMaintains$130.00+12.10%2024-10-08
Oppenheimer
Bottom 6%
6
BuyInitiates Coverage On$130.00+12.10%2024-10-08

1 of 2

Forecast return on equity

Is ABT forecast to generate an efficient return?

Company
27.17%
Industry
24.92%
Market
71.33%
ABT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ABT forecast to generate an efficient return on assets?

Company
14.63%
Industry
12.79%
ABT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ABT earnings per share forecast

What is ABT's earnings per share in the next 3 years based on estimates from 10 analysts?

Avg 1 year Forecast
$4.67+41.55%
Avg 2 year Forecast
$5.14+55.73%
Avg 3 year Forecast
$5.67+71.92%
ABT's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

ABT revenue forecast

What is ABT's revenue in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$42.0B+1.91%
Avg 2 year Forecast
$44.9B+8.95%
Avg 3 year Forecast
$48.0B+16.53%
ABT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ABT earnings growth forecast

How is ABT forecast to perform vs Medical Devices companies and vs the US market?

Company
19.68%
Industry
21.2%
Market
17.56%
ABT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
ABT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
ABT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

ABT revenue growth forecast

How is ABT forecast to perform vs Medical Devices companies and vs the US market?

Company
5.2%
Industry
6.55%
Market
8.9%
ABT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ABT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ABT vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
ABT$115.97$130.62+12.63%Buy
SYK$389.76$401.94+3.12%Strong Buy
BSX$90.84$95.00+4.58%Strong Buy
MDT$85.32$96.00+12.52%Buy
EW$74.20$75.79+2.14%Buy
View Top Medical Device Stocks

Abbott Laboratories Stock Forecast FAQ

Is Abbott Laboratories Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 13 Wall Street analysts covering (NYSE: ABT) stock is to Buy ABT stock.

Out of 13 analysts, 4 (30.77%) are recommending ABT as a Strong Buy, 5 (38.46%) are recommending ABT as a Buy, 4 (30.77%) are recommending ABT as a Hold, 0 (0%) are recommending ABT as a Sell, and 0 (0%) are recommending ABT as a Strong Sell.

If you're new to stock investing, here's how to buy Abbott Laboratories stock.

What is ABT's earnings growth forecast for 2024-2026?

(NYSE: ABT) Abbott Laboratories's forecast annual earnings growth rate of 19.68% is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 21.2%, and while it is forecast to beat the US market's average forecast earnings growth rate of 17.56%.

Abbott Laboratories's earnings in 2024 is $5,767,000,000.On average, 10 Wall Street analysts forecast ABT's earnings for 2024 to be $8,101,640,300, with the lowest ABT earnings forecast at $8,082,561,293, and the highest ABT earnings forecast at $8,117,250,397. On average, 10 Wall Street analysts forecast ABT's earnings for 2025 to be $8,913,365,340, with the lowest ABT earnings forecast at $8,845,721,586, and the highest ABT earnings forecast at $8,949,788,899.

In 2026, ABT is forecast to generate $9,840,084,760 in earnings, with the lowest earnings forecast at $9,712,949,193 and the highest earnings forecast at $9,955,772,923.

What is ABT's revenue growth forecast for 2024-2026?

(NYSE: ABT) Abbott Laboratories's forecast annual revenue growth rate of 5.2% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 6.55%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.9%.

Abbott Laboratories's revenue in 2024 is $41,217,000,000.On average, 8 Wall Street analysts forecast ABT's revenue for 2024 to be $72,857,879,506,141, with the lowest ABT revenue forecast at $72,626,843,133,949, and the highest ABT revenue forecast at $72,985,320,337,372. On average, 8 Wall Street analysts forecast ABT's revenue for 2025 to be $77,888,153,452,705, with the lowest ABT revenue forecast at $77,565,704,352,967, and the highest ABT revenue forecast at $78,118,128,338,307.

In 2026, ABT is forecast to generate $83,305,438,125,400 in revenue, with the lowest revenue forecast at $82,471,853,746,667 and the highest revenue forecast at $84,546,019,357,685.

What is ABT's forecast return on assets (ROA) for 2024-2027?

(NYSE: ABT) forecast ROA is 14.63%, which is higher than the forecast US Medical Devices industry average of 12.79%.

What is ABT's Price Target?

According to 13 Wall Street analysts that have issued a 1 year ABT price target, the average ABT price target is $130.62, with the highest ABT stock price forecast at $149.00 and the lowest ABT stock price forecast at $117.00.

On average, Wall Street analysts predict that Abbott Laboratories's share price could reach $130.62 by Nov 5, 2025. The average Abbott Laboratories stock price prediction forecasts a potential upside of 12.63% from the current ABT share price of $115.97.

What is ABT's Earnings Per Share (EPS) forecast for 2024-2026?

(NYSE: ABT) Abbott Laboratories's current Earnings Per Share (EPS) is $3.30. On average, analysts forecast that ABT's EPS will be $4.67 for 2024, with the lowest EPS forecast at $4.66, and the highest EPS forecast at $4.68. On average, analysts forecast that ABT's EPS will be $5.14 for 2025, with the lowest EPS forecast at $5.10, and the highest EPS forecast at $5.16. In 2026, ABT's EPS is forecast to hit $5.67 (min: $5.60, max: $5.74).

What is ABT's forecast return on equity (ROE) for 2024-2027?

(NYSE: ABT) forecast ROE is 27.17%, which is considered strong.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.